[Molecular imaging and molecular guided therapy].
OBJECTIVE
Scientific publications in the journal of Nuklearmedizin Molecular Imaging and Therapy during 2004/2005 were retrospectively examined for their potential classification to molecular imaging or molecular guided therapy, functional imaging and therapy, and were compared to earlier analyses.


RESULTS
Of the 57 original papers examined, 36 (63%) were assigned to the category of molecular imaging/molecular guided therapy. Within this category, the number of original papers on molecular guided therapy increased by 19% compared to preceding periods. There was a general overall increase in the proportion of experimental papers and more frequent inclusion of basic background subjects.


CONCLUSIONS
The development of molecular imaging as a direct instrument in therapy planning leads to further promotion of molecular guided therapy. The structural advantage of nuclear medicine, uniting method-lead diagnosis and therapy within one specialist subject, predestines it to advance molecular imaging and molecular guided therapy.
Lerch
H
H
Klinik für Nuklearmedizin, HELIOS-Klinikum Wuppertal, Universität Witten-Herdecke, Heusnerstr. 40, 42283 Wuppertal. hlerch@wuppertal.helios-kliniken.de
Jigalin
A
A
D006801:Humans; D007091:Image Processing, Computer-Assisted; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*